SCHEDULE OF WARRANT ACTIVITY (Details) - USD ($) |
9 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|||||||
| Income Tax Disclosure [Abstract] | |||||||||
| Number of Shares, Outstanding, Balance | 250 | [1] | 0.06 | 0.002 | |||||
| Weighted Average Price Per Share, Outstanding, Balance | $ 74,400 | $ 326,400,000 | $ 12,016,200,000 | ||||||
| Number of Shares, Granted | 250 | 0.06 | |||||||
| Weighted Average Price Per Share, Issued | $ 74,400 | $ 600,000 | |||||||
| Number of Shares, Exercised | (0.0002) | ||||||||
| Weighted Average Price Per Share, Exercised | $ 3,124,860,000 | ||||||||
| Number of Shares, Forfeited | (0.00002) | ||||||||
| Weighted Average Price Per Share, Forfeited | $ 120,000,000,000 | ||||||||
| Number of Shares, Expired | |||||||||
| Weighted Average Price Per Share, Expired | |||||||||
| Number of Shares, Exercised | 0.0002 | ||||||||
| Number of Shares, Forfeited | 0.00002 | ||||||||
| Number of Shares, Expired | |||||||||
| Number of Shares, Outstanding, Balance | 250 | [2] | 250 | [1] | 0.06 | ||||
| Weighted Average Price Per Share, Outstanding, Ending balance | $ 74,400 | $ 326,400,000 | |||||||
| Number of Shares, Exercisable, Balance | 250 | 250 | |||||||
| Weighted Average Price Per Share, Exercisable, Balance | $ 0.01 | $ 74,400 | |||||||
| Weighted average remaining contractual term | 1 year 3 months 3 days | 2 years 3 days | |||||||
| Aggregate intrinsic value | |||||||||
| |||||||||
| X | ||||||||||
- Definition Number of equity instruments other than options exercisable, including both vested and non-vested instruments. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average exercisable. No definition available.
|
| X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award, non-options equity instruments, weighted average.. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average price exercised. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average price expired. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average price forfeited. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average price issued. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options equity instruments outstanding weighted average remaining contractual terms. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options equity instruments aggregate intrinsic value outstanding. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|